StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
54
This month
3
This week
1
This year
11
Publishing Date
2024 - 04 - 15
1
2024 - 04 - 10
1
2024 - 04 - 01
1
2024 - 03 - 25
2
2024 - 03 - 19
1
2024 - 03 - 05
1
2024 - 02 - 27
1
2024 - 02 - 20
1
2024 - 01 - 23
1
2024 - 01 - 04
1
2023 - 12 - 11
1
2023 - 12 - 07
1
2023 - 11 - 22
1
2023 - 11 - 21
1
2023 - 11 - 06
1
2023 - 11 - 02
1
2023 - 10 - 31
1
2023 - 10 - 24
1
2023 - 10 - 11
1
2023 - 10 - 10
1
2023 - 10 - 02
1
2023 - 09 - 21
1
2023 - 09 - 07
1
2023 - 09 - 05
1
2023 - 08 - 07
1
2023 - 07 - 12
1
2023 - 07 - 07
1
2023 - 06 - 30
1
2023 - 06 - 28
2
2023 - 06 - 01
1
2023 - 05 - 30
1
2023 - 05 - 08
1
2023 - 05 - 03
1
2023 - 04 - 21
1
2022 - 12 - 07
1
2022 - 11 - 28
1
2022 - 10 - 27
1
2022 - 10 - 03
1
2022 - 08 - 19
1
2022 - 05 - 31
1
2022 - 03 - 11
1
2021 - 11 - 08
1
2021 - 10 - 20
1
2021 - 08 - 23
1
2021 - 04 - 26
1
2021 - 03 - 01
1
2021 - 02 - 19
1
2021 - 02 - 16
1
2020 - 12 - 31
2
2020 - 12 - 08
1
2020 - 12 - 02
1
Sector
Communications
1
Finance
2
Health technology
54
Tags
Alzheimer
1
Alzheimer's
1
Alzheimer's disease
1
Alzheimer’s
4
America
1
Annual needham
1
Application
1
Approval
1
Auvelity
3
Axs-05
3
Axs-12
1
Biopharma
1
Business
3
Company announcement
1
Conference
6
Congress
1
Day
1
Depression
4
Disease
4
Drug
2
Fda
2
Fda acceptance
1
Financial
8
Financial results
4
First
1
Global
3
Health
2
Major depressive disorder
6
Market
1
Meeting
5
N/a
52
Narcolepsy
3
Nasdaq
1
Neurology
1
New drug
2
Offering
3
Phase 3
3
Positive
4
Positive results
2
Presentation
1
Publication
1
Report
4
Research analysis and reports
1
Results
17
Revenue
1
Solriamfetol
6
Study
1
Sunosi
3
Symphony
1
Therapeutics
44
Today
2
Treatment
8
Trial
13
Trials
1
Update
4
Week
1
World
1
Year
3
Entities
Axsome therapeutics, inc.
54
Eli lilly and company
1
Hercules capital, inc.
1
Morgan stanley
1
Orange
1
Zymeworks inc.
1
Symbols
APO
348
ARVL
694
BKYI
195
BLK
356
BLNK
178
BMO
379
BNPQF
1342
BNPQY
1342
CM
210
CNHI
256
CNI
211
EQNR
297
FBIO
178
FCN
241
FNCTF
1139
FRBA
338
GMAB
227
GNMSF
174
GOLD
260
HII
314
JG
198
JNJ
553
LLY
200
LPLA
290
LTUM
308
MS
1199
MT
228
NDAQ
410
NOK
656
NOKBF
623
NVDA
199
NVO
342
NVS
226
NVSEF
173
PHG
210
PPRUF
366
PPRUY
366
RACE
195
RCI
181
RXT
228
RY
280
SNY
784
SNYNF
575
STLA
266
STM
272
STMEF
193
STOHF
230
TECK
199
TIXT
176
TNXP
192
TOL
389
TRP
177
TRU
242
TU
336
VRSK
181
VZ
892
WKEY
234
XELA
197
XYF
259
ZEAL
191
Exchanges
Nasdaq
54
Nyse
3
Crawled Date
2024 - 04 - 15
1
2024 - 04 - 10
1
2024 - 04 - 01
1
2024 - 03 - 25
2
2024 - 03 - 19
1
2024 - 03 - 05
1
2024 - 02 - 27
1
2024 - 02 - 20
1
2024 - 01 - 23
1
2024 - 01 - 04
1
2023 - 12 - 11
1
2023 - 12 - 07
1
2023 - 11 - 22
1
2023 - 11 - 21
1
2023 - 11 - 06
1
2023 - 11 - 02
1
2023 - 10 - 31
1
2023 - 10 - 24
1
2023 - 10 - 11
1
2023 - 10 - 10
1
2023 - 10 - 02
1
2023 - 09 - 21
1
2023 - 09 - 07
1
2023 - 09 - 05
1
2023 - 08 - 07
1
2023 - 07 - 12
1
2023 - 07 - 07
1
2023 - 06 - 30
1
2023 - 06 - 28
2
2023 - 06 - 01
1
2023 - 05 - 30
1
2023 - 05 - 08
1
2023 - 05 - 03
1
2023 - 04 - 21
1
2022 - 12 - 07
1
2022 - 11 - 28
1
2022 - 10 - 27
1
2022 - 10 - 03
1
2022 - 08 - 19
1
2022 - 05 - 31
1
2022 - 03 - 11
1
2021 - 11 - 08
1
2021 - 10 - 20
1
2021 - 08 - 23
1
2021 - 04 - 26
1
2021 - 03 - 01
1
2021 - 02 - 19
1
2021 - 02 - 16
1
2020 - 12 - 31
2
2020 - 12 - 08
1
2020 - 12 - 02
1
Crawled Time
00:00
1
11:00
26
11:01
1
11:02
1
11:03
1
12:00
16
12:03
2
12:04
1
12:15
1
12:20
1
12:30
1
13:20
1
20:00
1
Source
www.biospace.com
42
www.globenewswire.com
54
www.prnewswire.com
20
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
AXSM
source :
Www.globenewswire.com
save search
Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting
Published:
2024-04-15
(Crawled : 11:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
-7.61%
|
O:
-3.37%
H:
0.83%
C:
-0.76%
neurology
meeting
therapeutics
Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6
Published:
2024-04-10
(Crawled : 11:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
-9.53%
|
O:
-2.66%
H:
1.26%
C:
0.37%
first
report
therapeutics
financial
results
Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder
Published:
2024-04-01
(Crawled : 11:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
-17.38%
|
O:
0.32%
H:
0.0%
C:
-3.52%
treatment
trial
therapeutics
solriamfetol
Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy
Published:
2024-03-25
(Crawled : 11:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
-18.52%
|
O:
3.64%
H:
0.35%
C:
-7.48%
axs-12
narcolepsy
symphony
trial
therapeutics
Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients
Published:
2024-03-25
(Crawled : 11:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
-18.52%
|
O:
3.64%
H:
0.35%
C:
-7.48%
narcolepsy
therapeutics
results
Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder
Published:
2024-03-19
(Crawled : 11:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
-9.4%
|
O:
0.84%
H:
5.95%
C:
5.09%
treatment
trial
therapeutics
solriamfetol
Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference
Published:
2024-03-05
(Crawled : 12:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
-15.96%
|
O:
-0.45%
H:
0.86%
C:
-1.58%
conference
biopharma
global
therapeutics
Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
Published:
2024-02-27
(Crawled : 12:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
-20.15%
|
O:
0.75%
H:
2.12%
C:
1.3%
conference
therapeutics
Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published:
2024-02-20
(Crawled : 12:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
-29.19%
|
O:
-8.42%
H:
3.52%
C:
-4.54%
business
year
update
therapeutics
financial
results
Axsome Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20
Published:
2024-01-23
(Crawled : 12:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
-27.72%
|
O:
0.62%
H:
0.43%
C:
-2.14%
report
year
therapeutics
financial
results
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated Milestones
Published:
2024-01-04
(Crawled : 12:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
-13.63%
|
O:
2.6%
H:
9.85%
C:
5.02%
year
revenue
therapeutics
Axsome Therapeutics Presents New Data and Post-Hoc Analyses of Auvelity® in Patients with Major Depressive Disorder at the American College of Neuropsychopharmacology (ACNP) 2023 Annual Meeting
Published:
2023-12-11
(Crawled : 12:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
-6.36%
|
O:
-0.26%
H:
0.24%
C:
-0.5%
auvelity
meeting
therapeutics
Axsome Therapeutics Hosts Solriamfetol Virtual Investor Event with Expert Thought Leaders Today
Published:
2023-12-07
(Crawled : 12:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
-5.23%
|
O:
0.84%
H:
3.89%
C:
0.43%
therapeutics
solriamfetol
today
Axsome Therapeutics to Host Solriamfetol Virtual Investor Event on December 7
Published:
2023-11-22
(Crawled : 12:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
11.05%
|
O:
0.37%
H:
2.16%
C:
1.18%
therapeutics
solriamfetol
Axsome Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference
Published:
2023-11-21
(Crawled : 12:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
9.46%
|
O:
-1.42%
H:
1.79%
C:
-0.02%
conference
therapeutics
Axsome Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Published:
2023-11-06
(Crawled : 12:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
0.89%
|
O:
-4.67%
H:
10.55%
C:
0.52%
business
update
therapeutics
financial
results
Axsome Therapeutics and the Global Alzheimer’s Disease Community Come Together in Raising Support for the Millions Affected by This Illness During Alzheimer’s Disease Awareness Month 2023
Published:
2023-11-02
(Crawled : 11:00)
- globenewswire.com
FNCTF
|
News
|
$11.0354
320
|
Communications
|
-6.08%
|
O:
4.34%
H:
0.0%
C:
0.0%
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
1.7%
|
O:
1.13%
H:
1.36%
C:
-1.45%
disease
alzheimer’s
global
therapeutics
Axsome Therapeutics to Present at Upcoming Investor Conferences
Published:
2023-10-31
(Crawled : 11:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
9.48%
|
O:
0.0%
H:
3.76%
C:
3.75%
therapeutics
Axsome Therapeutics Presents Results of the ACCORD trial of AXS-05 in Alzheimer’s Disease Agitation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2023 Conference
Published:
2023-10-24
(Crawled : 11:00)
- globenewswire.com
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
5.98%
|
O:
1.98%
H:
2.15%
C:
0.76%
axs-05
conference
disease
alzheimer’s
trials
trial
therapeutics
results
Axsome Therapeutics Appoints Dr. Sue Mahony to its Board of Directors
Published:
2023-10-11
(Crawled : 11:00)
- globenewswire.com
ZYME
|
$8.89
2.54%
110K
|
Health Technology
|
37.21%
|
O:
-0.16%
H:
0.93%
C:
0.85%
LLY
|
$731.1
-1.99%
1M
|
Health Technology
|
31.55%
|
O:
4.47%
H:
2.11%
C:
1.52%
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
-6.86%
|
O:
-0.11%
H:
1.04%
C:
-0.41%
therapeutics
← Previous
1
2
3
Next →
Gainers vs Losers
79%
21%
Top 10 Gainers
AGBA
|
News
|
$1.22
205.0%
86M
|
Finance
EGOX
|
$0.0606
68.33%
250M
|
NVFY
|
$3.45
63.51%
20M
|
Consumer Durables
ZCMD
|
$1.98
36.55%
27M
|
Commercial Services
CHRO
|
$1.66
35.51%
70K
|
n/a
INDO
|
$5.43
33.09%
10M
|
Energy Minerals
PAPL
|
$2.07
26.22%
550K
|
RWOD
|
$10.08
26.05%
5.6M
|
n/a
AULT
|
$0.304
25.57%
47M
|
Manufacturing
HUSA
4
|
$2.07
23.95%
2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.